<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yu P</submitter><funding>MOST | National Natural Science Foundation of China (NSFC)</funding><funding>| Beijing Municipal Natural Science Foundation ()</funding><pagination>e0070324</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11774033</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>The widespread use of azole antifungals in agriculture and clinical settings has led to serious drug resistance. Overexpression of the azole drug target 14α-demethylase ERG11 (CYP51) is the most common fungal resistance mechanism. However, the presence of additional regulatory proteins in the transcriptional response of &lt;i>erg11&lt;/i> is not yet fully elucidated. In this study, leveraging the identified key promoter region of &lt;i>erg11&lt;/i> that controls its response to azoles in &lt;i>Neurospora crassa&lt;/i>, we pinpointed a protein, Crf4-3, which harbors a PWWP domain and exerts a positive regulatory influence on azole resistance, as determined by DNA pulldown assays. The removal of Crf4-3 results in heightened sensitivity to azoles while remaining unaffected by other stressors tested. Additional</pubmed_abstract><journal>mSphere</journal><pubmed_title>PWWP domain-containing protein Crf4-3 specifically modulates fungal azole susceptibility by regulating sterol C-14 demethylase ERG11.</pubmed_title><pmcid>PMC11774033</pmcid><funding_grant_id>No.32370082</funding_grant_id><funding_grant_id>No.32100056</funding_grant_id><funding_grant_id>No.5242020</funding_grant_id><pubmed_authors>Zhou M</pubmed_authors><pubmed_authors>Hu C</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Yu P</pubmed_authors><pubmed_authors>Ye S</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Sun X</pubmed_authors></additional><is_claimable>false</is_claimable><name>PWWP domain-containing protein Crf4-3 specifically modulates fungal azole susceptibility by regulating sterol C-14 demethylase ERG11.</name><description>The widespread use of azole antifungals in agriculture and clinical settings has led to serious drug resistance. Overexpression of the azole drug target 14α-demethylase ERG11 (CYP51) is the most common fungal resistance mechanism. However, the presence of additional regulatory proteins in the transcriptional response of &lt;i>erg11&lt;/i> is not yet fully elucidated. In this study, leveraging the identified key promoter region of &lt;i>erg11&lt;/i> that controls its response to azoles in &lt;i>Neurospora crassa&lt;/i>, we pinpointed a protein, Crf4-3, which harbors a PWWP domain and exerts a positive regulatory influence on azole resistance, as determined by DNA pulldown assays. The removal of Crf4-3 results in heightened sensitivity to azoles while remaining unaffected by other stressors tested. Additional</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-06-02T10:10:58.498Z</modification><creation>2025-04-03T23:26:44.54Z</creation></dates><accession>S-EPMC11774033</accession><cross_references><pubmed>39670730</pubmed><doi>10.1128/msphere.00703-24</doi></cross_references></HashMap>